| Pre-Clinical Services > Safety Efficacy | |||
| Efficacy Studies | |||
| • In-vivo Diabetes | • In-vivo Aphrodisiac | ||
| • In-vivo Anti-inflammatory | • In-vivo Antiulcer | ||
| • In-vivo Adaptogenic | • In-vivo Cholesterol lowering | ||
| • In-vivo Immunomodulatory | • In-vivo Anticancer | ||
| • In-vivo Drug Interaction | • In-vivo Antioxidant | ||
| Drug Metabolism and Pharmacokinetic Services | |||
| • Permeability (Caco2, MDCK) | |||
| • CYP Mediated Metabolism | |||
| • Protein Binding | |||
| • Microsomal Metabolic Stability | |||
| • PK & Routs of Excretion | |||
| • 14C Studies (Mass Balance)
Safety Pharmacology (ICH-S7A) Consultancy ► |
|||
